Los Angeles, California, United States OCV is the famous VC, which was founded in 2016. The main department of described VC is located in the Los Angeles. The venture was found in North America in United States.
The current fund was established by Mark Yung. Besides them, we counted 1 critical employee of this fund in our database.
This OCV works on 4 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. When the investment is from OCV the average startup value is 100-500 millions dollars. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019. The increased amount of exits for fund were in 2019.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the OCV, startups are often financed by Secocha Ventures, Accel, Ribbit Capital. The meaningful sponsors for the fund in investment in the same round are Secocha Ventures, Ortho Vision, venBio Partners. In the next rounds fund is usually obtained by Secocha Ventures, Ortho Vision.
The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Invoice2go, Finch Therapeutics Group, Ossio. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Software, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| CIMB | Kuala Lumpur, Malaysia |
| Columbia Ventures Corporation | - |
| Explore Ventures | - |
| Factor E Ventures | Colorado, Fort Collins, United States |
| Hengying Capital | Beijing, Beijing, China |
| Huarong Securities Shanghai Yanggao South Road Sales Department | China, Shanghai |
| Huibo Chengzhang Venture Capital | China, Guangdong, Shenzhen |
| Impact Venture | England, London, United Kingdom |
| InnoCapital | - |
| Innovate 21st | Istanbul, Istanbul, Turkey |
| Innovatus Capital Partners | New York, New York, United States |
| JT Financial Service | Japan, Tokyo |
| Less Plastics | Canada, Gatineau, Quebec |
| NCrypted Technologies | Ahmedabad, Gujarat, India |
| Qingkong Jinxin Blue Microbiology Fund | - |
| Shanghai Xuntian Investment | China, Shanghai |
| Startup UCLA Accelerator | California, Los Angeles, United States |
| Surround Ventures | New York, New York, United States |
| SX Capital, Inc. | Japan, Minato |
| The Rahn Group | Minneapolis, Minnesota, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TORL BioTherapeutics | $158M | 13 Apr 2023 | Los Angeles, California, United States | ||
Ozette Technologies | $26M | 28 Jul 2022 | New York, New York, United States | ||
Ockam | $12M | 05 Jan 2022 | San Francisco, California, United States | ||
Rad AI | $25M | 10 Nov 2021 | Berkeley, California, United States | ||
ByHeart | $90M | 26 Jul 2021 | New York, New York, United States | ||
Orca AI | $13M | 21 Apr 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States | ||
ByHeart | $70M | 15 Apr 2020 | New York, United States | ||
Finch Therapeutics | $53M | 21 Aug 2019 | Massachusetts, United States |
– Israeli startup Orca AI raised $13m in Series A funding.
– The round was led by OCV Partners, with principal Zohar Loshitzer joining Orca AI’s board.
– Mizmaa Ventures and Playfair Capital also participated.
– The company was founded by naval technology experts Yarden Gross and Dor Raviv.
– The latter is a former Israel navy computer vision expert.
– Customers include Kirby, Ray Car Carriers and NYK.
– Orca AI’s AI-based navigation and vessel tracking system supports ships in difficult to tricky to navigate situations and congested waterways, using vision sensors, thermal and low-light cameras, plus algorithms that look at the environment and alert crews to dangerous situations.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TORL BioTherapeutics | $158M | 13 Apr 2023 | Los Angeles, California, United States | ||
Ozette Technologies | $26M | 28 Jul 2022 | New York, New York, United States | ||
Ockam | $12M | 05 Jan 2022 | San Francisco, California, United States | ||
Rad AI | $25M | 10 Nov 2021 | Berkeley, California, United States | ||
ByHeart | $90M | 26 Jul 2021 | New York, New York, United States | ||
Orca AI | $13M | 21 Apr 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Praxis Precision Medicines | $110M | 28 Jul 2020 | Cambridge, Massachusetts, United States | ||
ByHeart | $70M | 15 Apr 2020 | New York, United States | ||
Finch Therapeutics | $53M | 21 Aug 2019 | Massachusetts, United States |
